862 related articles for article (PubMed ID: 26085146)
41. Polymorphic Forms of Human Cytomegalovirus Glycoprotein O Protect against Neutralization of Fibroblast Entry by Antibodies Targeting Epitopes Defined by Glycoproteins H and L.
He L; Taylor S; Costa C; Görzer I; Kalser J; Fu TM; Freed D; Wang D; Cui X; Hertel L; McVoy MA
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891489
[TBL] [Abstract][Full Text] [Related]
42. The conserved disulfide bond within domain II of Epstein-Barr virus gH has divergent roles in membrane fusion with epithelial cells and B cells.
Möhl BS; Sathiyamoorthy K; Jardetzky TS; Longnecker R
J Virol; 2014 Dec; 88(23):13570-9. PubMed ID: 25231307
[TBL] [Abstract][Full Text] [Related]
43. A cytomegalovirus DNA vaccine induces antibodies that block viral entry into fibroblasts and epithelial cells.
McVoy MA; Lee R; Saccoccio FM; Hartikka J; Smith LR; Mahajan R; Wang JB; Cui X; Adler SP
Vaccine; 2015 Dec; 33(51):7328-7336. PubMed ID: 26597035
[TBL] [Abstract][Full Text] [Related]
44. UL74 of human cytomegalovirus reduces the inhibitory effect of gH-specific and gB-specific antibodies.
Jiang XJ; Sampaio KL; Ettischer N; Stierhof YD; Jahn G; Kropff B; Mach M; Sinzger C
Arch Virol; 2011 Dec; 156(12):2145-55. PubMed ID: 21938463
[TBL] [Abstract][Full Text] [Related]
45. A Homolog Pentameric Complex Dictates Viral Epithelial Tropism, Pathogenicity and Congenital Infection Rate in Guinea Pig Cytomegalovirus.
Coleman S; Choi KY; Root M; McGregor A
PLoS Pathog; 2016 Jul; 12(7):e1005755. PubMed ID: 27387220
[TBL] [Abstract][Full Text] [Related]
46. Functional Relevance of the N-Terminal Domain of Pseudorabies Virus Envelope Glycoprotein H and Its Interaction with Glycoprotein L.
Vallbracht M; Rehwaldt S; Klupp BG; Mettenleiter TC; Fuchs W
J Virol; 2017 May; 91(9):. PubMed ID: 28228592
[TBL] [Abstract][Full Text] [Related]
47. Impact of sequence variation in the UL128 locus on production of human cytomegalovirus in fibroblast and epithelial cells.
Murrell I; Tomasec P; Wilkie GS; Dargan DJ; Davison AJ; Stanton RJ
J Virol; 2013 Oct; 87(19):10489-500. PubMed ID: 23885075
[TBL] [Abstract][Full Text] [Related]
48. Human cytomegalovirus gH/gL/UL128/UL130/UL131A complex elicits potently neutralizing antibodies in mice.
Wen Y; Monroe J; Linton C; Archer J; Beard CW; Barnett SW; Palladino G; Mason PW; Carfi A; Lilja AE
Vaccine; 2014 Jun; 32(30):3796-804. PubMed ID: 24837507
[TBL] [Abstract][Full Text] [Related]
49. Non-redundant and redundant roles of cytomegalovirus gH/gL complexes in host organ entry and intra-tissue spread.
Lemmermann NA; Krmpotic A; Podlech J; Brizic I; Prager A; Adler H; Karbach A; Wu Y; Jonjic S; Reddehase MJ; Adler B
PLoS Pathog; 2015 Feb; 11(2):e1004640. PubMed ID: 25659098
[TBL] [Abstract][Full Text] [Related]
50.
Gerna G; Kabanova A; Lilleri D
Vaccines (Basel); 2019 Jul; 7(3):. PubMed ID: 31336680
[TBL] [Abstract][Full Text] [Related]
51. Impact of Antibodies and Strain Polymorphisms on Cytomegalovirus Entry and Spread in Fibroblasts and Epithelial Cells.
Cui X; Freed DC; Wang D; Qiu P; Li F; Fu TM; Kauvar LM; McVoy MA
J Virol; 2017 Jul; 91(13):. PubMed ID: 28381568
[TBL] [Abstract][Full Text] [Related]
52. The structural basis of herpesvirus entry.
Connolly SA; Jardetzky TS; Longnecker R
Nat Rev Microbiol; 2021 Feb; 19(2):110-121. PubMed ID: 33087881
[TBL] [Abstract][Full Text] [Related]
53. Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion.
Kirschner AN; Lowrey AS; Longnecker R; Jardetzky TS
J Virol; 2007 Sep; 81(17):9216-29. PubMed ID: 17581996
[TBL] [Abstract][Full Text] [Related]
54. Dense Bodies of a gH/gL/UL128/UL130/UL131 Pentamer-Repaired Towne Strain of Human Cytomegalovirus Induce an Enhanced Neutralizing Antibody Response.
Lehmann C; Falk JJ; Büscher N; Penner I; Zimmermann C; Gogesch P; Sinzger C; Plachter B
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189713
[TBL] [Abstract][Full Text] [Related]
55. The KGD motif of Epstein-Barr virus gH/gL is bifunctional, orchestrating infection of B cells and epithelial cells.
Chen J; Rowe CL; Jardetzky TS; Longnecker R
mBio; 2012; 3(1):. PubMed ID: 22215569
[TBL] [Abstract][Full Text] [Related]
56. Immunization with Human Cytomegalovirus Core Fusion Machinery and Accessory Envelope Proteins Elicit Strong Synergistic Neutralizing Activities.
Cui X; Cao Z; Wang S; Adler SP; McVoy MA; Snapper CM
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32294946
[TBL] [Abstract][Full Text] [Related]
57. Cell Fusion Induced by a Fusion-Active Form of Human Cytomegalovirus Glycoprotein B (gB) Is Inhibited by Antibodies Directed at Antigenic Domain 5 in the Ectodomain of gB.
Reuter N; Kropff B; Schneiderbanger JK; Alt M; Krawczyk A; Sinzger C; Winkler TH; Britt WJ; Mach M; Thomas M
J Virol; 2020 Aug; 94(18):. PubMed ID: 32641474
[TBL] [Abstract][Full Text] [Related]
58. Cytomegalovirus UL131-128 products promote gB conformational transition and gB-gH interaction during entry into endothelial cells.
Patrone M; Secchi M; Bonaparte E; Milanesi G; Gallina A
J Virol; 2007 Oct; 81(20):11479-88. PubMed ID: 17686875
[TBL] [Abstract][Full Text] [Related]
59. Limited dissemination and shedding of the UL128 complex-intact, UL/b'-defective rhesus cytomegalovirus strain 180.92.
Assaf BT; Mansfield KG; Strelow L; Westmoreland SV; Barry PA; Kaur A
J Virol; 2014 Aug; 88(16):9310-20. PubMed ID: 24899204
[TBL] [Abstract][Full Text] [Related]
60. Characteristics and functions of human cytomegalovirus UL128 gene/protein.
Tao R; Xu J; Gao H-; Zhao W-; Shang S-
Acta Virol; 2014; 58(2):103-7. PubMed ID: 24957713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
